Quality of care measurement for patients with ovarian cancer in Japan.

Autor: Kakuwa T; Division of Health Services Research, Institute for Cancer Control, National Cancer Center, Tokyo, Japan.; Department of Public Health and Health Policy, Graduate School of Medicine, University of Tokyo, Tokyo, Japan., Watanabe T; Division of Health Services Research, Institute for Cancer Control, National Cancer Center, Tokyo, Japan.; Department of Public Health and Health Policy, Graduate School of Medicine, University of Tokyo, Tokyo, Japan., Niino M; Center for Cancer Registry, Institute for Cancer Control, National Cancer Center, Tokyo, Japan., Kawata A; Division of Health Services Research, Institute for Cancer Control, National Cancer Center, Tokyo, Japan.; Department of Gynecology, Saitama Cancer Center, Saitama, Japan., Satoh T; Department of Obstetrics and Gynecology, University of Tsukuba, Institute of Medicine, Tsukuba, Japan., Matsumura N; Department of Obstetrics and Gynecology, Faculty of Medicine, Kindai University, Osaka-sayama, Osaka, Japan., Yokoyama Y; Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, Aomori, Japan., Kawana K; Department of Obstetrics and Gynecology, Nihon University School of Medicine, Tokyo, Japan., Hirashima Y; Division of Gynecology, Shizuoka Cancer Center, Shizuoka, Japan., Kyo S; Department of Obstetrics and Gynecology, Shimane University School of Medicine, Shimane, Japan., Yasuda M; Department of Pathology, Saitama Medical University International Medical Center, Saitama, Japan., Harano K; Department of Experimental Therapeutics/Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan., Machida H; Department of Obstetrics and Gynecology, Tokai University, Kanagawa, Japan., Tokunaga H; Department of Gynecology, Tohoku University Hospital, Miyagi, Japan., Kaneuchi M; Department of Gynecology, Otaru General Hospital, Hokkaido, Japan., Tabata T; Department of Obstetrics and Gynecology, Tokyo Women's Medical University, Tokyo, Japan., Kobayashi Y; Department of Obstetrics and Gynecology, Kyorin University Faculty of Medicine, Tokyo, Japan., Nagase S; Department of Obstetrics and Gynecology, Faculty of Medicine, Yamagata University, Yamagata, Japan., Katabuchi H; Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan., Mikami M; Department of Obstetrics and Gynecology, Tokai University, Kanagawa, Japan., Yamamoto Y; Division of Health Services Research, Institute for Cancer Control, National Cancer Center, Tokyo, Japan., Rikitake R; Division of Health Services Research, Institute for Cancer Control, National Cancer Center, Tokyo, Japan.; Department of Public Health and Health Policy, Graduate School of Medicine, University of Tokyo, Tokyo, Japan., Ichinose Y; Division of Health Services Research, Institute for Cancer Control, National Cancer Center, Tokyo, Japan., Higashi T; Division of Health Services Research, Institute for Cancer Control, National Cancer Center, Tokyo, Japan.; Department of Public Health and Health Policy, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.; Center for Cancer Registry, Institute for Cancer Control, National Cancer Center, Tokyo, Japan.

Publikováno v: The journal of obstetrics and gynaecology research [J Obstet Gynaecol Res] 2024 Jul; Vol. 50 (7), pp. 1182-1191. Date of Electronic Publication: 2024 May 02.

Japan Society of Gynecologic Oncology 2022 guidelines for uterine cervical neoplasm treatment.

Autor: Seino M; Department of Obstetrics and Gynecology, Faculty of Medicine, Yamagata University, Yamagata, Japan. m-seino@med.id.yamagata-u.ac.jp., Nagase S; Department of Obstetrics and Gynecology, Faculty of Medicine, Yamagata University, Yamagata, Japan., Tokunaga H; Department of Gynecology and Obstetrics, Tohoku University Graduate School of Medicine, Sendai, Japan., Yamagami W; Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan., Kobayashi Y; Department of Obstetrics and Gynecology, Kyorin University, Faculty of Medicine, Tokyo, Japan., Tabata T; Department of Obstetrics and Gynecology, Tokyo Women's Medical University, Tokyo, Japan., Kaneuchi M; Department of Obstetrics and Gynecology, Otaru General Hospital, Hokkaido, Japan., Hirashima Y; Department of Gynecologic Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Niikura H; Department of Obstetrics and Gynecology, National Hospital Organization Sendai Medical Center, Sendai, Japan., Yoshino K; Department of Obstetrics and Gynecology, University of Occupational and Environmental Health, Kitakyushu, Japan., Takehara K; Department of Gynecologic Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan., Baba T; Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Shiwa, Japan., Katabuchi H; Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan., Mikami M; Department of Obstetrics and Gynecology, Tokai University, Kanagawa, Japan.

Publikováno v: Journal of gynecologic oncology [J Gynecol Oncol] 2024 Jan; Vol. 35 (1), pp. e15. Date of Electronic Publication: 2023 Nov 27.

Ovarian serous borderline tumors with recurrent or extraovarian lesions: a Japanese, retrospective, multi-institutional, population-based study.

Autor: Baba T; Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, 2-1-1 Idaidori, Yahaba-Cho, Shiwa, Iwate, 028-3695, Japan. babatsu@iwate-med.ac.jp.; Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-Cho, Sakyo-Ku, Kyoto, 606-8507, Japan. babatsu@iwate-med.ac.jp., Koshiyama M; Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-Cho, Sakyo-Ku, Kyoto, 606-8507, Japan., Kagabu M; Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, 2-1-1 Idaidori, Yahaba-Cho, Shiwa, Iwate, 028-3695, Japan., Mikami Y; Department of Diagnostic Pathology, Kumamoto University Hospital, 1-1-1 Honjo, Chuo-Ku, Kumamoto, 860-8556, Japan., Minamiguchi S; Department of Diagnostic Pathology, Kyoto University Hospital, 54 Shogoin-Kawahara-Cho, Sakyo-Ku, Kyoto, 606-8507, Japan., Moritani S; Department of Diagnostic Pathology, Shiga University of Medical Science Hospital, Setatsukinowa-Cho, Otsu, 520-2192, Japan., Ishikawa M; Department of Gynecology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan., Okamoto A; Department of Gynecology and Obstetrics, Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8461, Japan., Terao Y; Department of Gynecology and Obstetrics, Faculty of Medicine, Juntendo University, 3-1-3 Hongo, Bunkyo-Ku, Tokyo, 113-8431, Japan., Nakanishi T; Department of Gynecologic Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-Ku, Nagoya, 464-8681, Japan., Katabuchi H; Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-Ku, Kumamoto, 860-8556, Japan., Tokunaga H; Department of Gynecology and Obstetrics, Tohoku University Graduate School of Medicine, 2-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, 980-8675, Japan., Satoh T; Department of Gynecology and Obstetrics, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, 305-8575, Japan., Konishi I; Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-Cho, Sakyo-Ku, Kyoto, 606-8507, Japan., Yaegashi N; Department of Gynecology and Obstetrics, Tohoku University Graduate School of Medicine, 2-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, 980-8675, Japan.

Publikováno v: International journal of clinical oncology [Int J Clin Oncol] 2023 Oct; Vol. 28 (10), pp. 1411-1420. Date of Electronic Publication: 2023 Aug 01.

Hemoglobin-induced continuous activation of macrophages in endometriotic cysts: a potential mechanism of endometriosis development and carcinogenesis.

Autor: Kusunoki M; Department of Obstetrics and Gynecology, Faculty of Life Sciences, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.; Department of Cell Pathology, Faculty of Life Sciences, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan., Fujiwara Y; Department of Cell Pathology, Faculty of Life Sciences, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan., Komohara Y; Department of Cell Pathology, Faculty of Life Sciences, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan., Imamura Y; Department of Obstetrics and Gynecology, Faculty of Life Sciences, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan., Honda R; Department of Obstetrics and Gynecology, Faculty of Life Sciences, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan., Ohba T; Department of Obstetrics and Gynecology, Faculty of Life Sciences, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan., Katabuchi H; Department of Obstetrics and Gynecology, Faculty of Life Sciences, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan. buchi@kumamoto-u.ac.jp.

Publikováno v: Medical molecular morphology [Med Mol Morphol] 2021 Jun; Vol. 54 (2), pp. 122-132. Date of Electronic Publication: 2021 Jan 04.

Omental metastasis as a predictive risk factor for unfavorable prognosis in patients with stage III-IV epithelial ovarian cancer.

Autor: Iwagoi Y; Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, Kumamoto, 860-8556, Japan., Motohara T; Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, Kumamoto, 860-8556, Japan. kan@kumamoto-u.ac.jp., Hwang S; Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, Kumamoto, 860-8556, Japan., Fujimoto K; Department of Clinical Laboratory, Fukuoka University Hospital, 7-45-1, Nanakuma, Jonan-ku, Fukuoka, Fukuoka, 814-0180, Japan., Ikeda T; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Sojo University, 4-22-1, Ikeda, Nishi-ku, Kumamoto, Kumamoto, 860-0082, Japan.; Department of Medical Information Sciences and Administration Planning, Kumamoto University Hospital, 1-1-1 Honjo, Chuo-ku, Kumamoto, Kumamoto, 860-8556, Japan., Katabuchi H; Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, Kumamoto, 860-8556, Japan.

Publikováno v: International journal of clinical oncology [Int J Clin Oncol] 2021 May; Vol. 26 (5), pp. 995-1004. Date of Electronic Publication: 2021 Jan 29.